Atopic Dermatitis
📧 Sign up to get email alerts when something new happens for Atopic Dermatitis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2023-02-10Clinical Trial Update: Comparison of Lindioil (Indigo Naturalis Oil Extract) Ointment to Protopic® Ointment 0.1% in Treating Atopic Dermatitis [Phase 2]
Phase 2 trial comparing Lindioil ointment to Protopic ointment in atopic dermatitis has completed.
-
CLINICAL_TRIALS trial_result · 2023-02-08Clinical Trial Update: The Utility of Functionally Relevant Signature Genes in Assessing the Clinical Outcomes of Dupilumab Treatment [Phase 4]
Phase 4 trial evaluating functionally relevant signature genes to assess outcomes of dupilumab in atopic dermatitis/eczema.
-
CLINICAL_TRIALS trial_result · 2023-02-08Clinical Trial Update: Study Evaluating the Mechanism of Action of PF-04965842 Monotherapy for Moderate-to-severe Atopic Dermatitis [Phase 2]
Phase 2 trial update assessing PF-04965842 monotherapy for moderate-to-severe atopic dermatitis has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2023-01-27Clinical Trial Update: A Study of KY1005 in Patients With Moderate to Severe Atopic Dermatitis [Phase 2]
Phase 2 study evaluating KY1005 in patients with moderate to severe atopic dermatitis has completed.
-
CLINICAL_TRIALS trial_result · 2023-01-04Clinical Trial Update: The Study of CM326 in Moderate-to-severe Atopic Dermatitis [Phase 2]
Phase 2 clinical trial update for CM326 in moderate-to-severe atopic dermatitis is reported with unknown status.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2022-12-21Clinical Trial Update: Staphylococcus Aureus and The Skin Microbiome During Flare And Resolution Of Atopic Dermatitis [Phase 4]
Phase 4 trial investigating Staphylococcus aureus and skin microbiome dynamics during flare and resolution in atopic dermatitis.
-
CLINICAL_TRIALS withdrawal · 2022-12-19Clinical Trial Update: Comparison of JW-100 and EUCRISA for the Treatment of Atopic Dermatitis [Phase 3]
Phase 3 trial comparing JW-100 and EUCRISA for atopic dermatitis was withdrawn.
-
CLINICAL_TRIALS trial_result · 2022-12-07Clinical Trial Update: Evaluation of 611 in Chinese Adult Patients With Moderate-to-Severe Atopic Dermatitis [Phase 1, Phase 2]
Clinical trial update for evaluation of 611 in Chinese adults with moderate-to-severe atopic dermatitis (Phase 1/2) completed.
-
CLINICAL_TRIALS trial_result · 2022-12-06Clinical Trial Update: Effects of a Mixed Chinese Herbal Formula on Atopic Dermatitis [Phase 3]
Phase 3 clinical trial evaluating a mixed Chinese herbal formula for atopic dermatitis is ongoing with unknown status.
-
CLINICAL_TRIALS trial_result · 2022-12-01Clinical Trial Update: A Study in Patients With Atopic Eczema to Test How Effective BI 655130 is and How Well it is Tolerated [Phase 2]
A Phase 2 study evaluated the effectiveness and tolerability of BI 655130 in patients with atopic dermatitis, with results posted after comp…
-
CLINICAL_TRIALS trial_result · 2022-11-15Clinical Trial Update: Phase 2B Study to Evaluate ASN002 in Subjects With Moderate to Severe Atopic Dermatitis (RADIANT) [Phase 2]
Phase 2B study evaluating ASN002 for moderate-to-severe atopic dermatitis has completed; results posted in 2022.
-
CLINICAL_TRIALS trial_result · 2022-11-08Clinical Trial Update: A Study of Baricitinib (LY3009104) in Participants With Moderate to Severe Atopic Dermatitis [Phase 3]
Phase 3 trial of baricitinib in moderate to severe atopic dermatitis was terminated; results posted in 2022.
-
CLINICAL_TRIALS trial_result · 2022-11-04Clinical Trial Update: A Study to Assess the Safety and Efficacy of Etrasimod in Subjects With Moderate-to-Severe Atopic Dermatitis [Phase 2]
Phase 2 trial evaluating safety and efficacy of etrasimod for moderate-to-severe atopic dermatitis has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2022-11-02Clinical Trial Update: SAR231893-LPS15497- "Dupilumab Effect on Sleep in AD Patients" [Phase 4]
A Phase 4 trial assessing the effect of Dupixent (dupilumab) on sleep in adults with atopic dermatitis has completed, with results posted in…
-
CLINICAL_TRIALS trial_result · 2022-10-31Clinical Trial Update: ASPIRE: PROs & Caregiver Burden in Children With Atopic Dermatitis [Phase 3]
Phase 3 clinical trial update on PROs and caregiver burden in children with atopic dermatitis; results posted after completion.
-
CLINICAL_TRIALS trial_result · 2022-10-24Clinical Trial Update: Blinded, Randomized Study Evaluating Aurstat Versus Control in the Treatment of Atopic Dermatitis Associated Pruritus [Phase 2]
Phase 2 randomized trial evaluating Aurstat versus control for pruritus associated with atopic dermatitis has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2022-10-17Clinical Trial Update: A Multiple-Dose Study of BLU-5937 in Chronic Pruritus Associated With Atopic Dermatitis [Phase 2]
Phase 2 study evaluating multiple-dose BLU-5937 for chronic pruritus associated with atopic dermatitis has completed.
-
CLINICAL_TRIALS trial_result · 2022-10-10Clinical Trial Update: Study to Determine Safety and Efficacy of B244 in Subjects With Mild to Moderate Atopic Dermatitis [Phase 2]
Phase 2 study of B244 in mild to moderate atopic dermatitis completed, results posted in 2022.
-
CLINICAL_TRIALS trial_result · 2022-10-10Clinical Trial Update: Efficacy and Safety Study of Orally Administered DS107 in Moderate to Severe Atopic Dermatitis Patients [Phase 2]
Phase 2 trial assessing efficacy and safety of oral DS107 in moderate to severe atopic dermatitis has completed with posted results.
-
CLINICAL_TRIALS trial_result · 2022-10-07Clinical Trial Update: Safety and Efficacy Study of Topically Applied DS107 Cream in Mild to Moderate Atopic Dermatitis Patients (AD) [Phase 2]
Phase 2 clinical trial studying safety and efficacy of topically applied DS107 cream in mild to moderate atopic dermatitis; study completed …
-
CLINICAL_TRIALS trial_result · 2022-10-07Clinical Trial Update: Oral DS107 in Moderate to Severe Atopic Dermatitis [Phase 2]
Phase 2 trial update for oral DS107 in moderate to severe atopic dermatitis has been completed with results posted.
-
CLINICAL_TRIALS trial_result · 2022-09-27Clinical Trial Update: Study of the Safety, Tolerability and Efficacy of BTX 1204 in Patients With Moderate Atopic Dermatitis [Phase 2]
Phase 2 clinical trial evaluating BTX 1204 for safety, tolerability, and efficacy in moderate atopic dermatitis has completed with results p…
-
CLINICAL_TRIALS trial_result · 2022-09-22Clinical Trial Update: Tralokinumab in Combination With Topical Corticosteroids in Japanese Subjects With Moderate-to-severe Atopic Dermatitis [Phase 3]
Phase 3 trial evaluating Tralokinumab in combination with topical corticosteroids in Japanese patients with moderate-to-severe Atopic Dermat…
-
CLINICAL_TRIALS trial_result · 2022-09-16Clinical Trial Update: Evaluation of the Efficacy and Safety of Lebrikizumab (LY3650150) in Moderate to Severe Atopic Dermatitis [Phase 3]
Phase 3 trial evaluating the efficacy and safety of Lebrikizumab (LY3650150) in moderate to severe atopic dermatitis has completed with post…
-
CLINICAL_TRIALS trial_result · 2022-09-02Clinical Trial Update: A Study of QY201 Tablet in Subjects With Moderate to Severe Atopic Dermatitis [Phase 1, Phase 2]
Clinical trial update for QY201 Tablet in subjects with moderate to severe atopic dermatitis across Phase 1 and Phase 2.